Ali-Jackson Kamil

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$99,994.00
Insider Sells Quantity
14
Insider Sells Sum
$6.43M

Insider Activity of Ali-Jackson Kamil

The largest purchase of all time was on 2021-06-15 and amounted to 11764 shares of PDS Biotechnology Corporation for $99,994.

The largest sale of all time was on 2021-06-02 and amounted to 60238 shares of Aclaris Therapeutics, Inc. for $1.3M.

Biography of Ali-Jackson Kamil

No biography is available at this moment.

2021-06-15PurchasePDS Biotechnology Corporation
PDSB
11,764
0.0469%
$8.50$99,994-2.5%
2021-06-03SaleAclaris Therapeutics, Inc.
ACRS
Chief Legal Officer
18,984
0.0353%
$21.96$416,841-30.96%
2021-06-02SaleAclaris Therapeutics, Inc.
ACRS
Chief Legal Officer
60,238
0.1111%
$21.64$1.3M-30.08%
2021-06-01SaleAclaris Therapeutics, Inc.
ACRS
Chief Legal Officer
30,000
0.0541%
$23.02$690,598-35.49%
2021-05-07SaleAclaris Therapeutics, Inc.
ACRS
Chief Legal Officer
10,832
0.0206%
$23.52$254,784-31.61%
2021-05-06SaleAclaris Therapeutics, Inc.
ACRS
Chief Legal Officer
30,000
0.0547%
$23.43$702,906-34.12%
2021-05-05SaleAclaris Therapeutics, Inc.
ACRS
Chief Legal Officer
30,000
0.0552%
$23.98$719,426-34.71%
2021-05-04SaleAclaris Therapeutics, Inc.
ACRS
Chief Legal Officer
30,000
0.0556%
$23.68$710,374-33.21%
2021-05-03SaleAclaris Therapeutics, Inc.
ACRS
Chief Legal Officer
30,000
0.0548%
$24.59$737,637-36.56%
2018-06-12SaleAclaris Therapeutics, Inc.
ACRS
Chief Legal Officer
9,800
0.0315%
$20.00$196,000-59.36%
2018-06-11SaleAclaris Therapeutics, Inc.
ACRS
Chief Legal Officer
200
0.0007%
$20.00$4,000-58.64%
2018-05-18SaleAclaris Therapeutics, Inc.
ACRS
Chief Legal Officer
20,000
0.0645%
$20.00$400,000-53.1%
2016-10-26SaleAclaris Therapeutics, Inc.
ACRS
Chief Legal Officer
7,824
0.0178%
$11.68$91,345+23.37%
2016-09-28SaleAclaris Therapeutics, Inc.
ACRS
Chief Legal Officer
3,682
0.0086%
$12.69$46,725+6.9%
2016-08-26SaleAclaris Therapeutics, Inc.
ACRS
Chief Legal Officer
7,476
0.0333%
$20.35$152,137+26.62%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.